易恒健康IPO上市招股书（英文）-2019.10-301页_3mb

ECMOHO Limited Summary

Core Content

ECMOHO Limited is a Cayman Islands-based company that offers American Depositary Shares (ADSs) representing Class A ordinary shares of the company. The company is one of China's leading non-medical health and wellness integrated solution providers, with a mission to improve the health and well-being of Chinese consumers by providing quality products and trustworthy health content.

The offering is an initial public offering (IPO) of ADSs, with a proposed maximum aggregate offering price of US$150,000,000. The registration fee is US$18,180. The ADSs are expected to be listed on the NASDAQ Global Market under the symbol "MOHO". The underwriters have the option to purchase up to additional ADSs from selling shareholders within 30 days of the prospectus date.

Main Points

• Company Overview:

  • ECMOHO Limited is an emerging growth company under the JOBS Act.
  • It is a non-medical health and wellness integrated solution provider in China.
  • The company has a market share of 2.6% in the non-medical health and wellness integrated solution industry in 2018.
  • The industry is expected to grow at a CAGR of 20.3% from 2018 to 2023.

• Product and Service Portfolio:

  • Offers around 5,000 SKUs from 40 brand partners, including Abbott, Gerber, Perrier, Puritan's Pride, and Wyeth Nutrition.
  • Provides value-added services such as online store design and marketing campaigns.
  • Launched the XG Health platform in April 2019, an integrated family health management platform.
  • Operates offline and online channels, including Tmall, JD.com, Pinduoduo, and specialty stores in Anhui Province.

• Financial Highlights:

  • Net revenues grew by 102.6% from US$98.2 million in 2017 to US$199.0 million in 2018.
  • Net income attributable to ECMOHO Limited increased by 117.9% from US$2.8 million in 2017 to US$6.1 million in 2018.
  • Net income in the first half of 2019 was US$1.8 million, up from US$1.1 million in the first half of 2018.

• Share Structure:

  • After the offering, the company will issue Class A and Class B ordinary shares.
  • Class B shares carry 10 votes per share, while Class A shares carry 1 vote per share.
  • Class B shares are convertible into Class A shares on a one-for-one basis, while Class A shares are not convertible into Class B shares.
  • Co-founders Zoe Wang and Leo Zeng will beneficially own 100% of the issued Class B shares, making the company a controlled company under NASDAQ rules.

• Strategies:

  • Expand product and service offerings.
  • Increase offline channel coverage.
  • Enhance content generation and distribution.
  • Continue investment in consumer data and analytics.
  • Pursue strategic collaborations, investments, and acquisitions.

• Challenges:

  • Uncertainty in the growth of the e-commerce and health and wellness industries.
  • Managing business expansion and implementing strategies.
  • Adapting to changing consumer preferences.
  • Maintaining relationships with e-commerce platforms, brand partners, and content creators.
  • Competing effectively in the market.
  • Regulatory changes in China.
  • Inventory and warehousing management.

Key Information

• Corporate History:

  • Founded in December 2011 as Shanghai ECMOHO Health Biotechnology Co., Ltd..
  • Became exclusive distributor of Puritan's Pride in May 2013.
  • Launched Tmall Global flagship store in January 2014.
  • Partnered with Gerber Baby Products in July 2016 and Wyeth Nutrition in September 2017.
  • Incorporated as ECMOHO Limited in the Cayman Islands in June 2018.
  • Acquired 97.5% of ECMOHO Shanghai equity in July 2018.
  • Acquired the remaining 2.5% of ECMOHO Shanghai equity in June 2019.

• Legal and Regulatory:

  • The company is incorporated in the Cayman Islands and has its principal executive offices in Shanghai, China.
  • The agent for service of process in the U.S. is Corporation Service Company.
  • The company holds ICP licenses through its VIEs, but these entities have not generated meaningful revenues.
  • There are potential conflicts of interest with the VIE shareholders, who are also co-founders.

• Risk Factors:

  • The prospectus includes a detailed section on Risk Factors, highlighting the risks involved in investing in the ADSs.
  • Risks include market uncertainties, regulatory changes, competition, and corporate structure-related risks.

• Additional Information:

  • The prospectus includes a Table of Contents with detailed sections on financial data, management discussion, market opportunities, and legal matters.
  • The company is not a public company until the registration statement becomes effective.
  • The prospectus is subject to completion and not complete as of its date.

Summary of Financial and Operational Data

• Revenue (2018): US$199 million (up 103% YoY).
• Net Margin (2018): 3.1%.
• Net Income (2018): US$6.1 million (up 126% YoY).
• Net Income (H1 2019): US$1.8 million (up 63.6% from H1 2018).
• Paying Consumers (as of June 30, 2019): 7.2 million.
• Number of SKUs: ~5,000.
• Number of Brands: 62.
• Number of Healthcare Experts and KOLs: 1,100+.
• Number of Specialty Stores (as of August 31, 2019): 149.
• Content Generation (June 2019): Over 2,000 health and wellness articles.

Conclusion

ECMOHO Limited is a leading player in the non-medical health and wellness market in China, offering a wide range of products and services. The company is seeking to raise US$150 million through an IPO, with the ADSs to be listed on the NASDAQ Global Market. The offering is subject to certain risks, including market uncertainties, regulatory changes, and challenges in maintaining relationships and managing growth. The company's co-founders hold 100% of the Class B shares, making it a controlled company under NASDAQ rules. The prospectus provides detailed information on the company's financials, business model, and corporate structure.